A player’s draft year is supposed to be one of their most exciting years as a hockey player with their whole career ahead of them. But for Russian forward Ivan Miroshnichenko, it’s been derailed by what’s been reported as Hodgkin's lymphoma.
The Russian Ice Hockey Federation has said that Miroshnichenko will miss the remainder of this season and there is a chance that Miroshnichenko could miss the entirety of next season. He will receive treatment in Germany, just as fellow Russian and Toronto Maple Leafs prospect Rodion Amirov will be doing following his brain tumor diagnosis.
Survival rates are fairly high, especially for younger people diagnosed with rates around 80-85 percent. This is the same cancer diagnosis Mario Lemieux had.
Miroshnichenko started the year as one of the top prospects for the 2022 NHL draft. His blend of speed, power, and offensive prowess put him in conversations as a top-10 prospect for much of the year. Unfortunately, his draft stock and the prospect of being drafted are rightfully on the back burner for now as he fights this battle.
We here at The Hockey News and everyone in the hockey world are wishing Ivan all of the best as he fights this terrible disease.